BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 12841362)

  • 21. Oxidized low density lipoprotein: atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase.
    Kaplan M; Aviram M
    Clin Chem Lab Med; 1999 Aug; 37(8):777-87. PubMed ID: 10536926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential inhibition of oxidized LDL-induced apoptosis in human endothelial cells treated with different flavonoids.
    Jeong YJ; Choi YJ; Kwon HM; Kang SW; Park HS; Lee M; Kang YH
    Br J Nutr; 2005 May; 93(5):581-91. PubMed ID: 15975156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polyphenolic flavonoids inhibit macrophage-mediated oxidation of LDL and attenuate atherogenesis.
    Aviram M; Fuhrman B
    Atherosclerosis; 1998 Apr; 137 Suppl():S45-50. PubMed ID: 9694541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-atherosclerotic potential of gossypetin via inhibiting LDL oxidation and foam cell formation.
    Chen JH; Tsai CW; Wang CP; Lin HH
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):313-24. PubMed ID: 23845592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A method to screen for the antioxidant effect of compounds on low-density lipoprotein (LDL): illustration with flavonoids.
    Myara I; Pico I; Vedie B; Moatti N
    J Pharmacol Toxicol Methods; 1993 Oct; 30(2):69-73. PubMed ID: 8298183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidation of lipoproteins and atherosclerosis.
    Luc G; Fruchart JC
    Am J Clin Nutr; 1991 Jan; 53(1 Suppl):206S-209S. PubMed ID: 1985389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity toward LDL oxidation.
    Vaya J; Belinky PA; Aviram M
    Free Radic Biol Med; 1997; 23(2):302-13. PubMed ID: 9199893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification.
    Ishikawa T; Suzukawa M; Ito T; Yoshida H; Ayaori M; Nishiwaki M; Yonemura A; Hara Y; Nakamura H
    Am J Clin Nutr; 1997 Aug; 66(2):261-6. PubMed ID: 9250103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The isoflavone genistein inhibits copper and peroxyl radical mediated low density lipoprotein oxidation in vitro.
    Kerry N; Abbey M
    Atherosclerosis; 1998 Oct; 140(2):341-7. PubMed ID: 9862277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fisetin, morin and myricetin attenuate CD36 expression and oxLDL uptake in U937-derived macrophages.
    Lian TW; Wang L; Lo YH; Huang IJ; Wu MJ
    Biochim Biophys Acta; 2008 Oct; 1781(10):601-9. PubMed ID: 18662803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophages and oxidized low density lipoproteins in the pathogenesis of atherosclerosis.
    Ylä-Herttuala S
    Ann Med; 1991; 23(5):561-7. PubMed ID: 1721825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of flavonols as in vitro on low density lipoprotein glycation.
    Ghaffari MA; Mojab S
    Iran Biomed J; 2007 Jul; 11(3):185-191. PubMed ID: 18051779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morin hydrate inhibits azo-initiator induced oxidation of human low density lipoprotein.
    Wu TW; Fung KP; Wu J; Yang CC; Lo J; Weisel RD
    Life Sci; 1996; 58(2):PL 17-22. PubMed ID: 8606614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactive effects of polyphenols, tocopherol and ascorbic acid on the Cu2+-mediated oxidative modification of human low density lipoproteins.
    Yeomans VC; Linseisen J; Wolfram G
    Eur J Nutr; 2005 Oct; 44(7):422-8. PubMed ID: 15827683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flavonoids protect LDL from oxidation and attenuate atherosclerosis.
    Fuhrman B; Aviram M
    Curr Opin Lipidol; 2001 Feb; 12(1):41-8. PubMed ID: 11176202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antioxidant effect of flavonoids.
    Catapano AL
    Angiology; 1997 Jan; 48(1):39-44. PubMed ID: 8995342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidized low-density lipoprotein and atherosclerosis.
    Devaraj S; Jialal I
    Int J Clin Lab Res; 1996; 26(3):178-84. PubMed ID: 8905449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LDL-platelet interaction under oxidative stress induces macrophage foam cell formation.
    Aviram M
    Thromb Haemost; 1995 Jul; 74(1):560-4. PubMed ID: 8578524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The significance of ixidized low density lipoprotein in atherosclerosis].
    Hansen PR
    Ugeskr Laeger; 1996 May; 158(19):2706-10. PubMed ID: 8744072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of LDL alpha-tocopherol consumption, cholesterol oxidation, and vascular endothelium dysfunction by polyphenolic compounds from red wine.
    Deckert V; Desrumaux C; Athias A; Duverneuil L; Palleau V; Gambert P; Masson D; Lagrost L
    Atherosclerosis; 2002 Nov; 165(1):41-50. PubMed ID: 12208469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.